These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Bacterial phospholipases C as vaccine candidate antigens against cystic fibrosis respiratory pathogens: the Mycobacterium abscessus model. Le Moigne V; Rottman M; Goulard C; Barteau B; Poncin I; Soismier N; Canaan S; Pitard B; Gaillard JL; Herrmann JL Vaccine; 2015 Apr; 33(18):2118-24. PubMed ID: 25804706 [TBL] [Abstract][Full Text] [Related]
5. Type I interferon induced by TLR2-TLR4-MyD88-TRIF-IRF3 controls Mycobacterium abscessus subsp. abscessus persistence in murine macrophages via nitric oxide. Ruangkiattikul N; Rys D; Abdissa K; Rohde M; Semmler T; Tegtmeyer PK; Kalinke U; Schwarz C; Lewin A; Goethe R Int J Med Microbiol; 2019 Jul; 309(5):307-318. PubMed ID: 31178418 [TBL] [Abstract][Full Text] [Related]
6. The cell envelope of Mycobacterium abscessus and its role in pathogenesis. Parmar S; Tocheva EI PLoS Pathog; 2023 May; 19(5):e1011318. PubMed ID: 37200238 [TBL] [Abstract][Full Text] [Related]
7. Antimycobacterial activity of nonantibiotics associated with the polypharmacy of cystic fibrosis (CF) against mycobacterium abscessus. Kirkwood ZI; Millar BC; Downey DG; Moore JE Int J Mycobacteriol; 2018; 7(4):358-360. PubMed ID: 30531035 [TBL] [Abstract][Full Text] [Related]
8. Mycobacterium abscessus Strain Morphotype Determines Phage Susceptibility, the Repertoire of Therapeutically Useful Phages, and Phage Resistance. Dedrick RM; Smith BE; Garlena RA; Russell DA; Aull HG; Mahalingam V; Divens AM; Guerrero-Bustamante CA; Zack KM; Abad L; Gauthier CH; Jacobs-Sera D; Hatfull GF mBio; 2021 Mar; 12(2):. PubMed ID: 33785625 [No Abstract] [Full Text] [Related]
9. The distinct fate of smooth and rough Mycobacterium abscessus variants inside macrophages. Roux AL; Viljoen A; Bah A; Simeone R; Bernut A; Laencina L; Deramaudt T; Rottman M; Gaillard JL; Majlessi L; Brosch R; Girard-Misguich F; Vergne I; de Chastellier C; Kremer L; Herrmann JL Open Biol; 2016 Nov; 6(11):. PubMed ID: 27906132 [TBL] [Abstract][Full Text] [Related]
16. Beyond phenotype: The genomic heterogeneity of co-infecting Mycobacterium abscessus smooth and rough colony variants in cystic fibrosis patients. Gutiérrez AV; Baron SA; Sardi FS; Saad J; Coltey B; Reynaud-Gaubert M; Drancourt M J Cyst Fibros; 2021 May; 20(3):421-423. PubMed ID: 33610476 [TBL] [Abstract][Full Text] [Related]
17. Caskey S; Moore JE; Rendall JC Int J Mycobacteriol; 2018; 7(1):45-47. PubMed ID: 29516885 [TBL] [Abstract][Full Text] [Related]
18. Antimycobacterial activity of veterinary antibiotics (Apramycin and Framycetin) against Moore JE; Koulianos G; Hardy M; Misawa N; Millar BC Int J Mycobacteriol; 2018; 7(3):265-267. PubMed ID: 30198508 [TBL] [Abstract][Full Text] [Related]
19. Interaction of South Asian spices with conventional antibiotics: Implications for antimicrobial resistance for Moore RE; Millar BC; Panickar JR; Moore JE Int J Mycobacteriol; 2018; 7(3):257-260. PubMed ID: 30198506 [TBL] [Abstract][Full Text] [Related]
20. Essential engagement of Toll-like receptor 2 in initiation of early protective Th1 response against rough variants of Mycobacterium abscessus. Kim JS; Kang MJ; Kim WS; Han SJ; Kim HM; Kim HW; Kwon KW; Kim SJ; Cha SB; Eum SY; Koh WJ; Cho SN; Park JH; Shin SJ Infect Immun; 2015 Apr; 83(4):1556-67. PubMed ID: 25644006 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]